Back to Search
Start Over
Proactive screening for symptoms: A simple method to improve early detection of unrecognized cardiovascular disease in primary care. Results from the Lifelines Cohort Study.
- Source :
-
Preventive Medicine . Sep2020, Vol. 138, pN.PAG-N.PAG. 1p. - Publication Year :
- 2020
-
Abstract
- Cardiovascular disease (CVD) often goes unrecognized, despite symptoms frequently being present. Proactive screening for symptoms might improve early recognition and prevent disease progression or acute cardiovascular events. We studied the diagnostic value of symptoms for the detection of unrecognized atrial fibrillation (AF), heart failure (HF), and coronary artery disease (CAD) and developed a corresponding screening questionnaire. We included 100,311 participants (mean age 52 ± 9 years, 58% women) from the population-based Lifelines Cohort Study. For each outcome (unrecognized AF/HF/CAD), we built a multivariable model containing demographics and symptoms. These models were combined into one 'three-disease' diagnostic model and questionnaire for all three outcomes. Results were validated in Lifelines participants with chronic obstructive pulmonary disease (COPD) and diabetes mellitus (DM). Unrecognized CVD was identified in 1325 participants (1.3%): AF in 131 (0.1%), HF in 599 (0.6%), and CAD in 687 (0.7%). Added to age, sex, and body mass index, palpitations were independent predictors for unrecognized AF; palpitations, chest pain, dyspnea, exercise intolerance, health-related stress, and self-expected health worsening for unrecognized HF; smoking, chest pain, exercise intolerance, and claudication for unrecognized CAD. Area under the curve for the combined diagnostic model was 0.752 (95% CI 0.737-0.766) in the total population and 0.757 (95% CI 0.734-0.781) in participants with COPD and DM. At the chosen threshold, the questionnaire had low specificity, but high sensitivity. In conclusion, a short questionnaire about demographics and symptoms can improve early detection of CVD and help pre-select people who should or should not undergo further screening for CVD. [ABSTRACT FROM AUTHOR]
- Subjects :
- *SYMPTOMS
*CARDIOVASCULAR diseases
*INTERMITTENT claudication
*OBSTRUCTIVE lung diseases
*PRIMARY care
*COHORT analysis
*CARDIOVASCULAR disease diagnosis
*RESEARCH
*RESEARCH methodology
*MEDICAL cooperation
*EVALUATION research
*PRIMARY health care
*COMPARATIVE studies
*CORONARY artery disease
*LONGITUDINAL method
Subjects
Details
- Language :
- English
- ISSN :
- 00917435
- Volume :
- 138
- Database :
- Academic Search Index
- Journal :
- Preventive Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 144460257
- Full Text :
- https://doi.org/10.1016/j.ypmed.2020.106143